FdaApplication
NDA 216285
Identifiers
- fda_app_no: NDA216285
Properties
| Property | Value |
|---|---|
| applicant_name | EXELTIS USA INC |
| application_type | NDA |
| approval_date | 2022-06-29 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DROSPIRENONE | DROSPIRENONE | 3.5MG | TABLET, CHEWABLE;ORAL |
1 product